GSK PLC (GSK)
40.91
+0.05
(+0.12%)
USD |
NYSE |
Apr 25, 16:00
40.90
-0.02
(-0.04%)
After-Hours: 20:00
GSK Accounts Payable (Quarterly): 4.735B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.735B |
September 30, 2023 | 19.01B |
June 30, 2023 | 17.60B |
March 31, 2023 | 17.67B |
December 31, 2022 | 4.679B |
September 30, 2022 | 18.00B |
June 30, 2022 | 17.96B |
March 31, 2022 | 23.09B |
December 31, 2021 | 6.121B |
September 30, 2021 | 20.45B |
June 30, 2021 | 19.75B |
March 31, 2021 | 20.08B |
December 31, 2020 | 5.938B |
September 30, 2020 | 19.48B |
June 30, 2020 | 19.02B |
March 31, 2020 | 18.94B |
December 31, 2019 | 5.433B |
September 30, 2019 | 18.11B |
June 30, 2019 | 16.96B |
March 31, 2019 | 17.51B |
December 31, 2018 | 4.625B |
September 30, 2018 | 17.06B |
June 30, 2018 | 16.40B |
March 31, 2018 | 29.55B |
December 31, 2017 | 4.768B |
Date | Value |
---|---|
September 30, 2017 | 26.64B |
June 30, 2017 | 25.47B |
March 31, 2017 | 15.01B |
December 31, 2016 | 4.418B |
September 30, 2016 | 15.18B |
June 30, 2016 | 14.65B |
March 31, 2016 | 14.89B |
December 31, 2015 | 4.622B |
September 30, 2015 | 12.90B |
June 30, 2015 | 12.82B |
March 31, 2015 | 12.72B |
December 31, 2014 | 4.343B |
September 30, 2014 | 12.25B |
June 30, 2014 | 11.84B |
March 31, 2014 | 12.15B |
December 31, 2013 | 4.517B |
September 30, 2013 | 12.60B |
June 30, 2013 | 11.95B |
March 31, 2013 | 11.72B |
December 31, 2012 | 4.308B |
September 30, 2012 | 12.47B |
June 30, 2012 | 11.11B |
March 31, 2012 | 11.26B |
December 31, 2011 | 3.957B |
September 30, 2011 | 11.19B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.679B
Minimum
Dec 2022
23.09B
Maximum
Mar 2022
15.42B
Average
18.00B
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
AstraZeneca PLC | 3.267B |
Haleon PLC | 2.363B |
Novo Nordisk A/S | 3.802B |
Pfizer Inc | 6.71B |
Sanofi SA | 8.100B |